Press Releases

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

December 9, 2014

Ironwood Pharmaceuticals Initiates Phase IIa Clinical Study of IW-9179 in Diabetic Gastroparesis

November 20, 2014

Ironwood Earns $15 Million Milestone from Astellas upon Initiation of Enrollment in Linaclotide Phase III IBS-C Clinical Trial in Japan

November 5, 2014

Ironwood Pharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference

November 4, 2014

Ironwood Pharmaceuticals Initiates Phase III Trial of 72 mcg Linaclotide in Adult Patients with Chronic Idiopathic Constipation

November 4, 2014

Ironwood Pharmaceuticals Provides Third Quarter 2014 Investor Update

October 20, 2014

Ironwood Presents IW-9179 Phase IIa Data at American College of Gastroenterology 2014 Annual Scientific Meeting

October 16, 2014

Ironwood Pharmaceuticals Announces Initiation of Phase II Trial of Linaclotide in Adult Patients with Opioid-Induced Constipation

October 14, 2014

Ironwood Pharmaceuticals to Host Third Quarter 2014 Investor Update Call

October 9, 2014

Ironwood and Actavis to Present Linaclotide Data at the American College of Gastroenterology 2014 Annual Scientific Meeting

September 3, 2014

Ironwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference

September 2, 2014

Ironwood Appoints Two New Senior Executives to Support Continued Growth as a Leader in Gastroenterology

August 4, 2014

Ironwood Pharmaceuticals Provides Second Quarter 2014 Investor Update

July 7, 2014

Ironwood Pharmaceuticals to Host Second Quarter 2014 Investor Update Call

June 5, 2014

Ironwood Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference

June 4, 2014

Ironwood Pharmaceuticals Appoints Douglas Williams, Ph.D., to Board of Directors

May 7, 2014

Ironwood Pharmaceuticals to Present at Bank of America Merrill Lynch 2014 Healthcare Conference

May 1, 2014

Ironwood and Forest to Present Linaclotide Data at Digestive Disease Week® 2014

April 29, 2014

Ironwood Pharmaceuticals Provides First Quarter 2014 Investor Update

April 10, 2014

Ironwood and Forest Launch New Direct-to-Consumer Awareness Campaign For LINZESS®

April 8, 2014

Ironwood Pharmaceuticals to Host First Quarter 2014 Investor Update Call

March 18, 2014

Ironwood Pharmaceuticals Initiates Phase II Clinical Study of IW-3718 in Refractory Gastroesophageal Reflux Disease

February 24, 2014

Ironwood Pharmaceuticals to Present at Cowen and Company 34th Annual Health Care Conference

February 13, 2014

Ironwood Pharmaceuticals Announces Exercise of Underwriters' Option in Public Offering of Common Stock

February 12, 2014

Ironwood Pharmaceuticals Appoints Julie McHugh to Board of Directors

February 11, 2014

Ironwood Pharmaceuticals Prices Public Offering of Common Stock

February 10, 2014

Ironwood Pharmaceuticals Announces Proposed Public Offering of Common Stock

February 10, 2014

Ironwood Receives Notice of Allowance for Methods of Use Formulation Patent Expected to Extend LINZESS® Patent Protection Through 2031

February 7, 2014

Ironwood Pharmaceuticals to Present at Leerink Global Healthcare Conference

January 21, 2014

Ironwood Pharmaceuticals Provides Fourth Quarter 2013 Investor Update

January 8, 2014

Ironwood Pharmaceuticals Announces Alignment of Workforce with Priority Growth Platforms

January 7, 2014

Ironwood Pharmaceuticals to Host Fourth Quarter 2013 Investor Update Call

January 6, 2014

Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference